Sfoglia per Autore
Chemoenzymatic synthesis of the enantiomerically pure 1,2,3,4-tetrahydroquinoline moiety of the antithrombotic (21R)- and (21S)-argatroban
2013 P. Ferraboschi, S. Ciceri, P. Grisenti
Hydration of aromatic terminal alkynes catalyzed by iron(III) sulfate hydrate under chlorine-free conditions
2014 M. Bassetti, S. Ciceri, F. Lancia, C. Pasquini
Baker’s yeast catalyzed preparation of a new enantiomerically pure synthon of (S)-pramipexole and its enantiomer (dexpramipexole)
2014 P. Ferraboschi, S. Ciceri, P. Ciuffreda, M. De Mieri, D. Romano, P. Grisenti
Impiego di biocatalizzatori per trasformazioni selettive nella sintesi di molecole farmacologicamente attive
2014 S. Ciceri, P. Grisenti, P. Ferraboschi
Synthesis of the antitumoral nucleoside capecitabine through a chemo-enzymatic approach
2015 S. Ciceri, P. Ciuffreda, P. Grisenti, P. Ferraboschi
The biocatalytic approach to the preparation of Pramipexole
2015 B. Guidi, P. Ferraboschi, S. Ciceri, M.L. Contente, V. De Vitis, F. Molinari
Crystallographic and spectroscopic study on a known orally active progestin
2015 P. Ferraboschi, P. Ciuffreda, S. Ciceri, P. Grisenti, C. Castellano, F. Meneghetti
Synthesis of Antitumor Fluorinated Pyrimidine Nucleosides
2017 P. Ferraboschi, S. Ciceri, P. Grisenti
A Novel Versatile Precursor Suitable for 18F- Radiolabelling via “Click-Chemistry”
2017 B. Lugato, S. Stucchi, S. Ciceri, M.N. Iannone, E.A. Turolla, L. Giuliano, C. Chinello, S. Todde, P. Ferraboschi
A biocatalytic approach to the synthesis of pharmacologically active compounds
2018 S. Ciceri, B. Guidi, S. Reza Elahi, P. Ferraboschi
Biocatalytic Approach to the Synthesis of Pharmacologically Active Compounds
2018 P. Ferraboschi, S. Ciceri, B. Guidi, S. Reza Elahi, P. Grisenti
A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam
2018 S. Ciceri, P. Grisenti, S. Reza Elahi, P. Ferraboschi
The sad story of an anzymatic reaction in the fridge
2020 S. Ciceri, D. Colombo, F. Compostella, S. Reza Elahi, P. Ferraboschi
Crystallographic and NMR Investigation of Ergometrine and Methylergometrine, Two Alkaloids from Claviceps purpurea
2020 F. Meneghetti, P. Ferraboschi, P. Grisenti, S. Reza Elahi, M. Mori, S. Ciceri
Biocatalytic synthesis of two pharmacologically active compounds: (S)-pramipexole and its enantiomer, dexpramipexole.
2020 S. Ciceri, P. Ferraboschi, P. Grisenti, M. Mori, F. Meneghetti
(S)-Pramipexole and Its Enantiomer, Dexpramipexole : a New Chemoenzymatic Synthesis and Crystallographic Investigation of Key Enantiomeric Intermediates
2020 S. Ciceri, P. Ferraboschi, P. Grisenti, S. Reza Elahi, C. Castellano, M. Mori, F. Meneghetti
Biocatalysts for the synthesis of pharmacologically active compounds
2020 S. Ciceri, P. Grisenti, F. Meneghetti, M. Mori, S. Reza Elahi, P. Ferraboschi
Design, synthesis, characterization, and biological activity of new derivatives of elagolix, a potent GnRH antagonist
2021 S. Ciceri, D.R. Colombo, P. Ferraboschi, P. Grisenti, S.V. Sforna, F. Meneghetti
Low-Molecular-Weight Phosphatase B (LMW-MPtpB) inhibition as a strategy to identify new drug candidates against tuberculosis
2021 M. Mori, G. Cazzaniga, L.R. Chiarelli, G. Stelitano, S. Ciceri, T. Tuccinardi, G. Poli, F. Meneghetti, S. Villa
An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis
2021 M. Mori, S. Villa, S. Ciceri, D.R. Colombo, P. Ferraboschi, F. Meneghetti
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile